MarketHealth CareHealth Care Equipment & SuppliesHealth Care Equipment
BECTON DICKINSON & C

BDX

$152.14Apr 26, 2021Apr 24, 2026
Health CareHealth Care Equipment & SuppliesHealth Care Equipment$44.48B
MVM
+$359.9M
TD Variance
0.103

Every news event mapped to its market reaction — 151 events, 61 months of data. No predictions, just what happened.

PositiveNegativeNo data· Dot size = magnitude · Scroll to zoom · Drag to pan
Hover to inspect

Want the full written briefing?

The chart shows what moved — the briefing shows why. Sourced, dated, no hot takes.

Subscribe on Substack →

News Events

DateReturnCategorySourceHeadline
2025-05-01-20.7%legalSEC EDGARBDX 8-K: 2.02 and (SEC Filing)
2025-05-01-20.7%newsMarketWatchMedical-products maker Becton Dickinson says cuts in global research funding have hurt sales - MarketWatch
2025-08-07+11.5%legalSEC EDGARBDX 8-K: 2.02 and (SEC Filing)
2026-02-10+11.1%earningsSeeking AlphaBecton, Dickinson and Company: A Q1 2026 Earnings And Post Spin-Off Examination
2026-02-10+11.1%legalSEC EDGARBDX 8-K: 8.01 and (SEC Filing)
2026-02-10+11.1%earningsSeeking AlphaBecton, Dickinson and Company: A Q1 2026 Earnings And Post Spin-Off Examination - Seeking Alpha
2026-02-10+11.1%newsBenzingaWhat's Going On With Becton Dickinson Stock Tuesday? - Becton Dickinson (NYSE:BDX) - Benzinga
2026-02-10+11.1%newsFinvizJim Cramer on Becton, Dickinson: "I Kind of Really Like the New Company" - Finviz
2023-11-09-9.1%legalSEC EDGARBDX 8-K: 2.02 and (SEC Filing)
2025-02-05-7.0%legalSEC EDGARBDX 8-K: 2.02, 7.01 (SEC Filing)
2022-02-03+6.6%legalSEC EDGARBDX 8-K: 2.02 and (SEC Filing)
2023-07-24+6.3%legalSEC EDGARBDX 8-K: 5.02 (SEC Filing)
2021-08-05-6.2%legalSEC EDGARBDX 8-K: 8.01 and (SEC Filing)
2021-08-05-6.2%legalSEC EDGARBDX 8-K: 2.02, 5.02, 7.01 (SEC Filing)
2022-05-05+5.9%legalSEC EDGARBDX 8-K: 2.02 and (SEC Filing)
2021-05-06-5.7%legalSEC EDGARBDX 8-K: 8.01 and (SEC Filing)
2021-05-06-5.7%legalSEC EDGARBDX 8-K: 2.02, 7.01 (SEC Filing)
2025-12-10+5.3%M&ASeeking AlphaWaters raised to Outperform at Wolfe on BD Life Sciences deal
2023-05-04-4.9%legalSEC EDGARBDX 8-K: 2.02 and (SEC Filing)
2024-11-07-4.7%legalSEC EDGARBDX 8-K: 2.02 and (SEC Filing)
2022-04-18-4.7%legalSEC EDGARBDX 8-K: 8.01 (SEC Filing)
2022-04-06+4.5%legalSEC EDGARBDX 8-K: 5.02, 7.01, 8.01 (SEC Filing)
2026-02-03+4.3%M&ASeeking AlphaBecton, Dickinson resumed at buy at Citi on biosciences unit spinoff
2026-02-03+4.3%newsFinvizPiper Sandler Highlights Upcoming Segment Transition at Becton Dickinson (BDX) - Finviz
2022-08-04+4.0%legalSEC EDGARBDX 8-K: 2.02 and (SEC Filing)
2026-02-09+3.8%earningsSeeking AlphaBecton Dickinson outlines $12.35–$12.65 EPS guidance for 2026 with $4B cash deployment following Waters transaction
2026-02-09+3.8%earningsSeeking AlphaBecton, Dickinson and Company (BDX) Q1 2026 Earnings Call Transcript
2026-02-09+3.8%earningsSeeking AlphaBecton, Dickinson and Company 2026 Q1 - Results - Earnings Call Presentation
2026-02-09+3.8%earningsSeeking AlphaBD slips despite Q1 beat as life sciences unit underperforms
2026-02-09+3.8%earningsSeeking AlphaBecton, Dickinson beats top-line and bottom-line estimates; updates FY26 EPS outlook
2026-02-09+3.8%legalSEC EDGARBDX 8-K: 1.01, 5.02, 7.01, 8.01 (SEC Filing)
2026-02-09+3.8%legalSEC EDGARBDX 8-K: 2.02 and (SEC Filing)
2026-02-09+3.8%earningsChartMillBECTON DICKINSON AND CO (NYSE:BDX) Beats Q1 FY2026 Estimates but Shares Fall in Pre-Market - ChartMill
2026-02-09+3.8%earningsReutersBecton Dickinson lowers 2026 profit forecast, shares fall - Reuters
2026-02-09+3.8%newsBenzingaBecton Dickinson, ON Semiconductor And 3 Stocks To Watch Heading Into Monday - Becton Dickinson (NYSE:BDX - Benzinga
2026-02-09+3.8%earningsBenzingaBecton Dickinson Slashes Profit Outlook Post-Spinoff - Becton Dickinson (NYSE:BDX) - Benzinga
2026-02-09+3.8%earningsBenzingaDow Falls 250 Points; Becton Dickinson Posts Upbeat Earnings - Benzinga
2023-02-02-3.7%legalSEC EDGARBDX 8-K: 2.02 and (SEC Filing)
2026-01-14+3.6%analystSeeking AlphaBecton, Dickinson And Company: Rightfully Re-Rated (Downgrade)
2024-08-01+3.6%legalSEC EDGARBDX 8-K: 2.02 and (SEC Filing)
2026-02-25-3.5%legalSEC EDGARBDX 8-K: 8.01 and (SEC Filing)
2023-01-06-3.4%legalSEC EDGARBDX 8-K: 5.02, 7.01 (SEC Filing)
2024-02-01-3.1%legalSEC EDGARBDX 8-K: 2.02 and (SEC Filing)
2026-01-13+3.0%newsSeeking AlphaBD invests $110M in Nebraska to boost U.S. drug delivery solutions
2023-02-13-2.9%legalSEC EDGARBDX 8-K: 1.01, 2.03 (SEC Filing)
2022-04-14-2.8%legalSEC EDGARBDX 8-K: 2.02 and (SEC Filing)
2026-04-23-2.6%earningsZacksWest Pharmaceutical Services (WST) Q1 Earnings and Revenues Beat Estimates
2026-02-18+2.6%newsGuruFocusInsider Sell: Bertram Scott Sells Shares of Becton Dickinson & C - GuruFocus
2026-03-31-2.6%earningsMarketBeatPacific Capital Partners Ltd Buys 8,250 Shares of Becton, Dickinson and Company $BDX - MarketBeat
2021-08-11+2.6%legalSEC EDGARBDX 8-K: 5.02, 7.01 (SEC Filing)
2025-05-02-2.4%earningsYahoo FinanceBecton Dickinson & Co (BDX) Q2 2025 Earnings Call Highlights: Strong EPS Growth Amid ... - Yahoo Finance
2026-04-09-2.3%legalSEC EDGARBDX 8-K: 5.02, 7.01 (SEC Filing)
2021-11-30+2.2%legalBecton Dickinson4: Statement of changes in beneficial ownership of securities - Becton Dickinson
2022-11-10-2.2%legalSEC EDGARBDX 8-K: 2.02 and (SEC Filing)
2021-11-04-2.2%legalSEC EDGARBDX 8-K: 2.02 and (SEC Filing)
2025-01-10+2.1%legalSEC EDGARBDX 8-K: 5.02, 7.01 (SEC Filing)
2025-01-23+2.1%newsIntellectia AIBDX Forecast — Price Prediction for 2026. Should I Buy BDX? - Intellectia AI
2025-03-27+2.1%legalSEC EDGARBDX 8-K: 5.02 (SEC Filing)
2026-02-06-2.0%earningsSeeking AlphaBecton, Dickinson Q1 2026 Earnings Preview
2026-02-02+1.8%newsFinvizBecton, Dickinson and Company (BDX): A Bull Case Theory - Finviz
2026-01-23-1.8%newsSeeking AlphaNovo Nordisk Wegovy pill uptake negatively impacts syringe makers
2026-01-23-1.8%analystChartMillBecton, Dickinson and Co (NYSE:BDX) Shows High Technical and Setup Ratings for Potential Breakout - ChartMill
2025-11-06+1.8%earningsSeeking AlphaBecton Dickinson outlines $200M cost reduction and targets $14.75–$15.05 EPS for 2026 while expanding sales force
2025-11-06+1.8%earningsSeeking AlphaBecton, Dickinson and Company (BDX) Q4 2025 Earnings Call Transcript
2025-11-06+1.8%earningsSeeking AlphaBecton, Dickinson reports mixed Q4 results; initiates FY26 outlook
2025-11-06+1.8%newsSeeking AlphaBecton, Dickinson declares $1.05 dividend
2025-11-06+1.8%legalSEC EDGARBDX 8-K: 2.02 and (SEC Filing)
2025-11-06+1.8%earningsChartMillBECTON DICKINSON AND CO (NYSE:BDX) Shares Slide on Q4 Revenue Miss Despite EPS Meet - ChartMill
2026-04-22-1.8%newsGlobeNewswire$10+ Bn Microbiology Testing Market Analysis by Product, Technology, End User - Global Forecast to 2031
2026-04-22-1.8%executiveZacksZacks Industry Outlook Highlights Cardinal, Becton and The Cooper
2024-05-02-1.8%legalSEC EDGARBDX 8-K: 2.02 and (SEC Filing)
2026-01-02+1.7%newsAD HOC NEWSThe Truth About Becton Dickinson & Co (BDX): Quiet Giant Or Sleeper Stock You’re Sleeping On? - AD HOC NEWS
2024-08-30+1.6%legalSEC EDGARBDX 8-K: 5.02 and (SEC Filing)
2025-07-14+1.6%legalSEC EDGARBDX 8-K: 1.01 and (SEC Filing)
2025-07-14+1.6%M&AMarketWatchBecton Dickinson gets its spinoff deal, but the stock is still falling - MarketWatch
2023-07-14-1.6%newsintelligentinvestor.com.auBecton Dickinson and Co (NYSE:BDX) - intelligentinvestor.com.au
2025-12-01-1.6%legalSEC EDGARBDX 8-K: 5.02 and (SEC Filing)
2026-04-17+1.5%newsMotley FoolThe Healthcare Stock Built for Investors Who Prioritize Capital Preservation
2025-10-15-1.4%executiveSeeking AlphaBDX appoints Vitor Roque as interim CFO
2025-10-15-1.4%earningsSeeking AlphaBecton, Dickinson slips as FQ4, 2025 revenue estimates just below consensus
2025-10-15-1.4%legalSEC EDGARBDX 8-K: 2.02, 5.02, 7.01 (SEC Filing)
2025-10-15-1.4%executiveBecton DickinsonBD Announces CFO Transition Plan :: Becton, Dickinson and Company (BDX) - Becton Dickinson
2025-11-17+1.4%legalSEC EDGARBDX 8-K: 5.02 and (SEC Filing)
2025-10-22-1.4%newsYahoo FinanceWhat Makes Becton Dickinson & Co. (BDX) a Good Investment? - Yahoo Finance
2025-12-18-1.3%executiveQuiver QuantitativeBECTON DICKINSON & CO ($BDX) CEO 2025 Pay Revealed - Quiver Quantitative
2023-08-03-1.2%legalSEC EDGARBDX 8-K: 2.02 and (SEC Filing)
2023-03-10+1.2%legalSEC EDGARBDX 8-K: 1.01, 2.03 (SEC Filing)
2026-04-02-1.2%legalSEC EDGARBDX 8-K: 2.02 and (SEC Filing)
2026-04-02-1.2%newsMarketWatchBecton Dickinson & Co. stock underperforms Thursday when compared to competitors - MarketWatch
2026-02-12-1.1%newsSure DividendDividend Aristocrats In Focus: Becton, Dickinson & Co. - Sure Dividend
2026-01-27-1.1%newsSeeking AlphaBecton, Dickinson declares $1.05 dividend
2026-01-27-1.1%M&AStock TitanBD carves out biosciences arm, $4B Waters deal nears Feb. 9 - Stock Titan
2026-01-27-1.1%newsStock TitanBD to pay $4.20 a share, authorizes buyback of 10M more shares - Stock Titan
2024-02-27-1.1%legalSEC EDGARBDX 8-K: 5.02, 7.01 (SEC Filing)
2021-09-13+1.1%newsThe Motley FoolBecton, Dickinson - BDX - Stock Price & News - The Motley Fool
2026-03-10-1.1%newsSeeking AlphaBecton, Dickinson and Company (BDX) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
2025-10-20-1.1%newsSeeking AlphaBecton, Dickinson and Company: A Dividend Idea With Diverse Medtech Portfolio To Meet Future Demand
2022-03-31+1.1%legalSEC EDGARBDX 8-K: 5.02, 7.01 (SEC Filing)
2025-12-22-1.0%newsSeeking AlphaBecton, Dickinson accused of hindering competition in hernia mesh market
2026-02-19+1.0%M&AStock TitanWalgreens deal veteran Lanesha Minnix to lead BD legal and public affairs - Stock Titan
2021-08-13+1.0%legalSEC EDGARBDX 8-K: 1.01, 2.03, 8.01 (SEC Filing)
2021-08-30+1.0%legalSEC EDGARBDX 8-K: 5.02 (SEC Filing)
2025-09-18-1.0%legalSEC EDGARBDX 8-K: 1.01, 2.03 (SEC Filing)
2022-08-08+0.9%legalSEC EDGARBDX 8-K: 8.01 and (SEC Filing)
2021-09-27+0.9%legalSEC EDGARBDX 8-K: 1.01, 2.03 (SEC Filing)
2025-10-09-0.8%earningsStock TitanNov. 6 webcast: Q4 & FY2025 results — BD to discuss financials, operations and strategy - Stock Titan
2025-02-08-0.8%newsCNBCStarboard pushes an open door at Becton Dickinson as company seeks to separate its biosciences unit - CNBC
2024-02-06+0.7%legalSEC EDGARBDX 8-K: 8.01 and (SEC Filing)
2025-11-07+0.7%earningsSeeking AlphaBecton, Dickinson and Company: Strong Earnings But Murky Outlook
2024-02-15+0.7%newsCNNsymbol__ Stock Quote Price and Forecast - CNN
2022-08-09-0.7%legalSEC EDGARBDX 8-K: 8.01 and (SEC Filing)
2022-05-31-0.6%legalSEC EDGARBDX 8-K: 2.02 and (SEC Filing)
2023-11-27-0.6%legalSEC EDGARBDX 8-K: 5.02 and (SEC Filing)
2025-11-18+0.6%earningsSeeking Alpha1578 Partners initiates new position in Becton, Dickinson and Company in Q3
2025-11-18+0.6%newsSeeking AlphaBecton, Dickinson: Our New, Long, Special Situation Investment
2025-11-08+0.6%earningsSeeking AlphaBecton, Dickinson and Company 2025 Q4 - Results - Earnings Call Presentation
2021-08-19-0.6%legalSEC EDGARBDX 8-K: 8.01 and (SEC Filing)
2021-08-10+0.5%legalSEC EDGARBDX 8-K: 8.01 and (SEC Filing)
2021-07-12-0.5%legalSEC EDGARBDX 8-K: 5.02 and (SEC Filing)
2026-02-13-0.5%newsFinvizCiti Raises Becton Dickinson (BDX) PT to $198 after Life Sciences Sale Update - Finviz
2024-06-07-0.5%legalSEC EDGARBDX 8-K: 1.01, 2.03 (SEC Filing)
2021-10-22-0.5%legalSEC EDGARBDX 8-K: 5.02 (SEC Filing)
2026-03-14-0.4%newsSeeking AlphaU.S. to ease restrictions on carcinogenic gas used for sterilizing medical devices
2025-10-13-0.4%earningsSeeking AlphaClearBridge Value Strategy adds AMZN, TSM, CRM, exits INTC, ABBV, EXPE among Q3 moves
2024-07-12-0.4%legalSEC EDGARBDX 8-K: 1.01, 2.03 (SEC Filing)
2026-02-05+0.4%legalSEC EDGARBDX 8-K: 3.02, 5.03 (SEC Filing)
2022-08-22-0.4%legalSEC EDGARBDX 8-K: 8.01 and (SEC Filing)
2026-01-15-0.3%legalStock TitanFDA clears new BD device aimed at improving breast biopsies for patients - Stock Titan
2026-04-20-0.3%newsZacksHere Are 3 Medical Supply Stocks to Consider Amid Rising Prospects
2026-04-20-0.3%earningsBarchartWhat You Need to Know Ahead of Becton, Dickinson and Company's Earnings Release
2026-04-20-0.3%newsSeeking AlphaBecton, Dickinson: Value Or Overvalued Even Now?
2026-04-19+0.3%newsSimply Wall St.Becton Dickinson Wins Supply Chain Honors As Valuation Appears Undemanding
2026-04-18+0.3%newsGuruFocusKANAWHA CAPITAL MANAGEMENT LLC's Becton Dickinson & Co(BDX) Holding History - GuruFocus
2026-01-16-0.3%newsInvesting.comBecton Dickinson EVP Garrison sells $334,005 in BDX stock - Investing.com
2025-08-26-0.3%newsGuruFocusInsider Sell: Michael Feld Sells Shares of Becton Dickinson & Co (BDX) - GuruFocus
2025-04-27-0.3%newsSeeking AlphaBecton, Dickinson and Company: It's Wait And See For Me (NYSE:BDX) - Seeking Alpha
2026-01-07+0.2%newsAD HOC NEWSThe Truth About Becton Dickinson and Co (BDX): Quiet Healthcare Giant, Loud Money Moves - AD HOC NEWS
2023-01-25+0.2%legalSEC EDGARBDX 8-K: 1.01, 2.03 (SEC Filing)
2022-08-25+0.2%legalSEC EDGARBDX 8-K: 5.02, 7.01 (SEC Filing)
2022-03-26+0.2%newsmarketscreener.comBecton, Dickinson and Company Stock (BDX) - Quote Nyse - marketscreener.com
2026-01-30+0.2%legalSEC EDGARBDX 8-K: 5.02, 5.07 (SEC Filing)
2025-11-05-0.2%earningsSeeking AlphaBecton, Dickinson Q4 2025 Earnings Preview
2023-02-07-0.2%legalSEC EDGARBDX 8-K: 8.01 and (SEC Filing)
2022-03-01+0.2%legalSEC EDGARBDX 8-K: 5.02 (SEC Filing)
2025-11-25-0.1%legalTradingViewBECTON DICKINSON & CO SEC 10-K Report - TradingView
2022-03-21-0.1%legalSEC EDGARBDX 8-K: 3.02, 5.03, 8.01 (SEC Filing)
2023-01-30-0.0%legalSEC EDGARBDX 8-K: 5.02, 5.07 (SEC Filing)
2026-04-26newsInsider MonkeyPiper Sandler Trims Becton Dickinson (BDX) PT on Model Revisions
2026-04-24earningsGuruFocus.comBecton Dickinson at 13x Earnings: MedTech's Most Mispriced Compounder
2026-04-24newsInsider MonkeyBecton Dickinson and Company (BDX): Gold Standard Defensive Stock
2026-04-24newsMarketWatchBecton Dickinson & Co. stock underperforms Friday when compared to competitors - MarketWatch
tickerdossier.comtickerdossier.substack.com